Net profit of Titan Biotech rose 2.76% to Rs 6.70 crore in the quarter ended September 2024 as against Rs 6.52 crore during the previous quarter ended September 2023. Sales declined 8.15% to Rs 39.89 crore in the quarter ended September 2024 as against Rs 43.43 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 39.89 | 43.43 | -8 |
| OPM % | 19.45 | 20.08 | - |
| PBDT | 7.81 | 8.99 | -13 |
| PBT | 6.72 | 8.13 | -17 |
| NP | 6.70 | 6.52 | 3 |